Welcome to our dedicated page for Hillenbrand SEC filings (Ticker: HI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Hillenbrand, Inc. (HI) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Hillenbrand’s Form 8-K filings, earnings releases, and proxy-related documents describe its activities as a global industrial company that provides highly engineered, mission-critical processing equipment and solutions for end markets such as durable plastics, food, and recycling.
Through these filings, investors can review current reports on Form 8-K that cover material events, including the entry into an Agreement and Plan of Merger with LSF12 Helix Parent, LLC and LSF12 Helix Merger Sub, Inc., affiliates of Lone Star Funds. The filings explain that, under this agreement, Merger Sub will merge with and into Hillenbrand, with Hillenbrand surviving as a wholly owned subsidiary of Parent, and that the transaction is structured as an all-cash acquisition at a specified per-share price, subject to customary closing conditions.
Other 8-K filings document shareholder actions and governance matters, such as the special meeting at which Hillenbrand shareholders voted to approve the merger agreement, advisory votes on compensation related to the merger, and adjournment proposals. Additional filings describe litigation and shareholder demands relating to proxy disclosures and provide supplemental information incorporated into the definitive proxy statement.
Hillenbrand’s SEC reports also address capital structure and financing arrangements. Filings outline amendments and restatements of credit agreements, including revolving credit facilities and term loans, as well as amendments to a syndicated L/G facility. They also describe the redemption of senior notes and the terms of new debt commitments associated with the pending merger. A Form 8-K dated January 9, 2026 discusses change of control offers for Hillenbrand’s senior notes due 2029 and 2031, including pricing and conditions tied to the merger and ratings events.
In connection with its earnings releases, Hillenbrand files 8-Ks that furnish financial results and discuss the use of non-GAAP measures such as adjusted EBITDA, adjusted net income, and pro forma adjusted EBITDA. These filings explain the items excluded from these measures and reference reconciliations to GAAP metrics. On Stock Titan, AI-powered tools can help summarize and interpret these disclosures, highlight key terms of the merger agreement and financing covenants, and surface relevant information about leverage ratios, dividend restrictions, and other conditions that may affect shareholders and noteholders.
Daniel C. Hillenbrand, a director of Hillenbrand, Inc. (HI), filed a Form 4 reporting transactions dated 09/30/2025. The filing shows a disposition of 3,448 shares of common stock. It also details multiple indirect beneficial holdings held through trusts and entities, including 20,000, 8,631, 28,248, 48,611, 135,863, and 5,754 shares attributed to various trusts and partnerships.
The filing also reports the grant/settlement of several Restricted Stock Units on 09/30/2025, with specific vested units of 9, 24, 36, 25, 23, 24, 26, and 34 units converting to beneficial ownership totals of 1,111, 2,942, 4,400, 3,099, 2,862, 2,913, 3,165, and 4,122 shares respectively. The RSUs carry dividend equivalent rights and varying vesting rules as explained in the filing.
Tamara Morytko, Sr. VP & President, MTS of Hillenbrand, Inc. (HI), reported changes in her holdings on a Form 4 covering transactions dated 09/30/2025 and 10/01/2025. The filing shows a disposition of 5,671 shares of common stock (Table I, Code V). It also records the settlement/conversion of multiple Restricted Stock Unit grants into common shares: 70, 39, 92, and 10 shares reported on 09/30/2025, and a 2,248-share settlement on 10/01/2025. Each RSU is shown with a $0 price reflecting settlement in shares, and the filing lists the post-transaction beneficial ownership totals for each grant line.
Bhavik N. Soni, Senior Vice President & Chief Information Officer of Hillenbrand, Inc. (HI), filed a Form 4 reporting several equity changes dated 09/30/2025 and signed 10/02/2025. The filing shows a disposition of 13,392 shares of Hillenbrand common stock and multiple acquisitions of Restricted Stock Units (RSUs) granted under prior award dates. The RSU entries record 5, 14, 25, 4, and 34 RSUs added to Mr. Soni's holdings, each settled in common stock and carrying dividend-equivalent rights.
The RSUs vest on specified schedules (one-third annual tranches for most awards) with one Matching RSU tied to the Executive Share Match framework vesting on March 31, 2028. After these transactions the filing reports updated beneficial ownership totals per award (for example 4,235 shares following the Matching RSU entry). The Form 4 discloses only the transactions and vesting schedules; no prices were paid for the RSUs and no additional commentary is included.
Kimberly K. Ryan, listed as President & CEO and a Director of Hillenbrand, Inc. (HI), reported transactions with an earliest transaction date of 09/30/2025. The filing shows a reported disposition of 175,565.745 shares of common stock (Code V), reducing her direct holdings. On the same date she acquired several restricted stock unit awards that convert into common shares: 83, 237, 432, and 312 RSUs, which correspond to 10,116, 28,788, 52,423, and 37,829 shares beneficially owned following each reported award, respectively. Vesting schedules and the matching RSU framework are disclosed in the filing.
Dennis W. Pullin, a director of Hillenbrand, Inc. (HI), reported acquisitions of restricted stock units on 09/30/2025. The Form 4 shows five separate deferred restricted stock unit awards tied to grant dates of 5/7/21, 2/10/22, 2/24/23, 2/20/24, and 2/18/25, resulting in additions of 9, 23, 24, 26, and 34 units respectively (totaling 116 RSUs). Each RSU represents the right to receive one share and carries dividend equivalent rights. The RSUs vest on the earlier of the next annual meeting or one year from grant but accelerate upon a change in control, the director’s death or permanent disability, or one day after the director ceases to be a director. The filing was signed by an attorney-in-fact on 10/02/2025.
Joy M. Greenway, a director of Hillenbrand, Inc. (HI), was awarded a series of Restricted Stock Units on 09/30/2025. The Form 4 reports the acquisition of 368 RSUs across awards dated 2013–2025 (individual grant amounts: 21, 33, 33, 38, 27, 24, 24, 36, 25, 23, 24, 26, 34). Each RSU represents the right to one share and the awards carry dividend equivalent rights; the reported per-share price is $0 because these are compensation awards rather than market purchases.
The filing notes vesting rules: some older awards vest immediately but have post-service holding requirements, while more recent awards vest at the next annual meeting or one year from grant and include accelerated vesting on a change in control, death, or disability. The Form 4 was filed by an attorney-in-fact on behalf of Ms. Greenway and shows these transactions were reported as acquisitions of derivative securities that convert into common stock.
Carole Anne Phillips, Senior Vice President & Chief Procurement Officer of Hillenbrand, Inc. (HI), reported changes in beneficial ownership on 09/30/2025. The Form 4 shows the acquisition (settlement) of multiple Restricted Stock Units (RSUs): 4 RSUs from a 12/07/2022 award (bringing that award's underlying common stock total to 578 shares), 13 RSUs from a 12/07/2023 award (total 1,629 shares), 23 RSUs from a 12/05/2024 award (total 2,824 shares), and 23 Matching RSUs under the Executive Share Match framework (listed as 2,788 underlying shares). Each RSU represents the contingent right to one share and RSUs carry dividend equivalence where noted. The filing was signed by an attorney-in-fact on 10/02/2025.
Helen W. Cornell, a director of Hillenbrand, Inc. (HI), reported transactions dated 09/30/2025. The filing shows indirect beneficial ownership of 11,691 shares held by the Helen W. Cornell 2020 Irrevocable Trust and 1,500 shares held by the Helen W. Cornell Rev. Trust. On 09/30/2025 Ms. Cornell was credited with 490 Restricted Stock Units (RSUs) across awards dating from 2012 through 2025. Several RSU grants vest immediately or under short schedules and carry dividend-equivalent rights; vesting and share delivery are subject to the issuer’s holding rules and specified conditions such as the next annual meeting or one year from grant for certain awards. The form is signed by an attorney-in-fact on 10/02/2025.
Hillenbrand director Inderpreet Sawhney reported receipt of restricted stock units on 09/30/2025. The filing lists five deferred stock awards totaling 114 Restricted Stock Units (7, 23, 24, 26, and 34 units). Each unit represents a contingent right to one share of common stock and carries dividend equivalent rights. The units have zero purchase price and vest on the earlier of the next annual meeting or one year from grant, with immediate vesting if a change in control, the director's death or disability, or the director’s termination occurs.
Insider transactions by Tamara Morytko, Sr. VP & President, MTS at Hillenbrand, Inc. (HI) show restricted stock units vesting and a partial sale of common stock on 09/11/2025. 4,245 Restricted Stock Units (granted 09/11/2023) were recorded as acquired/vested with a $0 per-share conversion value and dividend-equivalent rights. On the same date, 1,997 shares of common stock were disposed of at $25.365 per share. Post-transaction beneficial ownership figures in the filing are presented as 7,668 and 5,671 shares in the non-derivative table and 8,498 shares in the derivative table reflecting RSU holdings. The form is signed by an Attorney-in-Fact on 09/15/2025.
FAQ
What is the current stock price of Hillenbrand (HI)?
What is the market cap of Hillenbrand (HI)?
